[1] |
Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group[J]. Allergy, 2016, 71(2): 149⁃161. DOI: 10.1111/all.12774.
|
[2] |
Brockow K, Romano A, Blanca M, et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity[J]. Allergy, 2002, 57(1): 45⁃51. DOI: 10.1046/j.0105⁃4538.2001. 00001.x⁃i8.
|
[3] |
Wilkinson DS, Fregert S, Magnusson B, et al. Terminology of contact dermatitis[J]. Acta Derm Venereol, 1970, 50(4): 287⁃292.
|
[4] |
Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations[J]. Allergy, 2003, 58(9): 854⁃863. DOI: 10.1034/j.1398⁃9995.2003.00279.x.
|
[5] |
Chiriac AM, Demoly P. Drug provocation tests: up⁃date and novel approaches[J]. Allergy Asthma Clin Immunol, 2013, 9(1): 12. DOI: 10.1186/1710⁃1492⁃9⁃12.
|
[6] |
Barbaud A, Collet E, Milpied B, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions[J]. Br J Dermatol, 2013, 168(3): 555⁃562. DOI: 10.1111/bjd.12125.
|
[7] |
Barbaud A. Skin testing and patch testing in non⁃IgE⁃mediated drug allergy[J]. Curr Allergy Asthma Rep, 2014, 14(6): 442. DOI: 10.1007/s11882⁃014⁃0442⁃8.
|
[8] |
Ohtoshi S, Kitami Y, Sueki H, et al. Utility of patch testing for patients with drug eruption[J]. Clin Exp Dermatol, 2014, 39(3): 279⁃283. DOI: 10.1111/ced.12239.
|
[9] |
Andrade P, Brinca A, Gonçalo M. Patch testing in fixed drug eruptions: a 20⁃year review[J]. Contact Derm, 2011, 65(4): 195⁃201. DOI: 10.1111/j.1600⁃0536.2011.01946.x.
|
[10] |
Chung WH, Hung SI, Yang JY, et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens⁃Johnson syndrome and toxic epidermal necrolysis[J]. Nat Med, 2008, 14(12): 1343⁃1350. DOI: 10.1038/nm.1884.
|
[11] |
Lee HY, Chung WH. Toxic epidermal necrolysis: the year in review[J]. Curr Opin Allergy Clin Immunol, 2013, 13(4): 330⁃336. DOI: 10.1097/ACI.0b013e3283630cc2.
|
[12] |
Ponvert C, Perrin Y, Bados⁃Albiero A, et al. Allergy to betalactam antibiotics in children: results of a 20⁃year study based on clinical history, skin and challenge tests[J]. Pediatr Allergy Immunol, 2011, 22(4): 411⁃418. DOI: 10.1111/j.1399⁃3038.2011.01169.x.
|
[13] |
Finkelstein Y, Soon GS, Acuna P, et al. Recurrence and outcomes of Stevens⁃Johnson syndrome and toxic epidermal necrolysis in children[J]. Pediatrics, 2011, 128(4): 723⁃728. DOI: 10.1542/peds.2010⁃3322.
|
[14] |
Lin YT, Chang YC, Hui RC, et al. A patch testing and cross⁃sensitivity study of carbamazepine⁃induced severe cutaneous adverse drug reactions[J]. J Eur Acad Dermatol Venereol, 2013, 27(3): 356⁃364. DOI: 10.1111/j.1468⁃3083.2011.04418.x.
|